Johnson & Johnson (JNJ)
240.40
+0.77
(+0.32%)
USD |
NYSE |
Mar 06, 16:00
239.99
-0.41
(-0.17%)
After-Hours: 20:00
Johnson & Johnson EPS Diluted (Quarterly) : 2.098 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.455 |
| Gilead Sciences, Inc. | 1.742 |
| Eli Lilly & Co. | 7.024 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Moderna, Inc. | -2.107 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.116B |
| Revenue (Quarterly) | 24.56B |
| Total Expenses (Quarterly) | 19.45B |
| Enterprise Value | 608.57B |
| Gross Profit Margin (Quarterly) | 66.77% |
| Profit Margin (Quarterly) | 20.83% |
| Earnings Yield | 4.59% |
| Operating Earnings Yield | 4.39% |
| Normalized Earnings Yield | 3.958 |